Daily Newsletter

16 August 2023

Daily Newsletter

16 August 2023

Medela to launch new Invia Integrated Dressing for wounds

The new dressing has been designed to work with Medela NPWT Liberty and Motion pumps.

RanjithKumar Dharma August 16 2023

Medela has announced plans to expand its negative pressure wound therapy (NPWT) portfolio with the introduction of the new Invia Integrated Dressing indicated for all types of wounds.

The new sterile dressing is intended for all wound types, including closed surgical incisions. It is suitable for use at home or in a hospital setting for up to seven days.

In July this year, the company received approval from the US Food and Drug Administration (FDA) for the ‘peel-and-stick’ adhesive, Invia Integrated Dressing.

It comes with a three-layer fluid handling pad that has a skin-friendly silicone adhesive border.

The new dressing also features a Quick-connector, which is present in all of the company’s NPWT products for pump-to-dressing connections.

It has been designed to work with the Liberty and Motion Medela NPWT pumps.

These pumps help maintain even pressure while drawing away fluids and keeping them away from the wound site to support healing.

Medela CEO Annette Brüls said: “Backed by more than six decades of expertise in medical vacuum technology, this long-awaited product will be available in September as an extension of our full-system solution to support wound healing.

“When we set out to support this category, we applied our research-based suction technology to our negative pressure wound therapy solutions and we’ve found that this provides an optimal environment for confident and effective wound healing.”

Medela's NPWT solutions include Intelligent Pressure Control, which ensures the application of a steady and uniform pressure directly to the wound site.

Furthermore, the Medela system consists of Dynamic Exudate Removal technology, which utilises double-lumen tubing for preventing blockages and removing exudates.

The technology also aids in adjusting to changing fluid levels, drawing fluid from the wound into a canister and supporting the body's natural healing and tissue regeneration processes.

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close